There are no sets in this subject.
No groups found.
| aripiprazole definitions | |||
|---|---|---|---|
| # | Definition | Sets | |
| 1 | abilify | 43 sets | |
| 2 | atypical antipsychotic | 5 sets | |
| 3 | ablify | 2 sets | |
| 4 | abilify : : atypical antipsychotic agent : : schizophrenia | 2 sets | |
| 5 | antipsychotic: schizophrenia | 2 sets | |
| 6 | partial agonist d2receptors= 5-ht2a> d4> α1 contraindicated in the elderly and diabetics | 1 set | |
| 7 | abilify *antipsychotic | 1 set | |
| 8 | antipsychotic | 1 set | |
| 9 | 2, 5, 10, 15, 20, 30 mg a day | 1 set | |
| 10 | atypical antipsychotic (neuroleptic) | 1 set | |
| 11 | abilify ®, atypical antipsychotic s/e: **neuroleptic malignant syndrome (nms), **tardive dyskinesia (td), akathisia (eps), *weight gain, *hyperglycemia, *diabetes mellitis (dm), *othrostatic htn, dizziness, insomnia, nausea, vomiting, sedation | 1 set | |
| 12 | partial agonist at d2 & 5ht1a receptors, -- 5ht2a maybe reason for negative mood. | 1 set | |
| 13 | strongly blocks postsynaptic d2 in cns. high potency. very low eps, and sedation. no inc in prolactin. low wt gain, long half life, novel mech potential | 1 set | |
| 14 | low eps, low/mild ach and oh, low sed, new, little or no weight gain or increase in glucose, hdl, ldl, or triglycerides levels | 1 set | |
| 15 | atypical antipsychotic that can be used as a mood stabilizer (possibly helpful in the long term); recently approved; partial d2 and 5ht1a agonist; minimal weight gain | 1 set | |
| 16 | abilify : : atypical antipsychotic agent : : schizophrenia bipolar and major depressive disorder | 1 set | |
| 17 | antipsychotics; dopamine system stabilizer, partial agonist at d2 and 5ht1a serotonin receptors, antagonist 5ht2a | 1 set | |
| 18 | abilify/antipsychotic agent | 1 set | |
| 19 | abilify, antipsychotic (a), schiz, bp, mdd | 1 set | |
| 20 | antipsychotic agent, atypical | 1 set | |
| 21 | bipolar disorder, adjuct to treatment of mdd, schizophrenia | 1 set | |
| 22 | (abilify) | 1 set | |
| 23 | antipsychotics; dopamine system stabilizer, partial agonist at d2 and 5ht1a serotonin receptors, antagonist 5ht2a, | 1 set | |
| 24 | treatment of schizophrenia and adjunctive therapy of bipolar disorder | 1 set | |
| 25 | abilify antipsychotic agent, atypical schizophrenia, bipolar, mdd | 1 set | |
| 26 | (abilify), atypical antipsychotic | 1 set | |
| 27 | atyptical antipsychotic that blocks 5ht-2a receptors, and is also a partial agonist of d2 and 5ht-1a receptors | 1 set | |
| 28 | antipsychotics; dopamine system stabilizer; partial agonist at d2 and 5-ht1a; antagonist at 5-ht2a | 1 set | |
| 29 | atypical antipsychotic, biopolar, major depressive, schizophrenia, and acute agitation | 1 set | |
| 30 | abilify® | 1 set | |